Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
Marijuana in Combination with Opioids for Cancer Pain
Donald Abrams, M.D.
Cannabis for Spasticity/Tremor in MS: Placebo Controlled Study
Mark Agius, M.D.
Cannabinoids in Fear Extinction
Mark Barad, M.D., Ph.D.
Treating Chemotherapy-Induced Delayed Nausea with Cannabinoids
Suzanne Dibble, DNSc, RN
MMJ for HIV-associated DSPN: Adherence & Compliance Sub-Study
Dennis Israelski, M.D.
Analgesic Efficacy of Smoked Cannabis in Refractory Cancer Pain
Mark Wallace, M.D.
Studies Under Review
New in Cannabinoid Research
Involvement of the nucleus accumbens shell glutamatergic system in ACPA-induced impairment of inhibitory avoidance memory consolidation.
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.
New in Cannabinoid Trials
The Impact of CBT-I on Cannabis Cessation Outcomes
Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Combined Pharmacotherapy for Cannabis Dependency
Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH |
University of California, San Diego
| contact the